Visceral leishmaniasis masquerading as autoimmune disease flare in a non-endemic area: diagnostic challenges and the role of targeted next-generation sequencing.

Int J Infect DisJun 6, 2026 (epub)

Yuke Tian, Linjie Zhong, Xin Zhao

✦ AI-curated · Sources linked

Case in brief

A 57-year-old woman with a history of systemic lupus erythematosus and Sjögren syndrome presented with anorexia, vomiting, intermittent fever, and splenomegaly. Initial tests revealed marked hypergammaglobulinaemia and progressive pancytopenia. Targeted next-generation sequencing identified Leishmania donovani, leading to a diagnosis of visceral leishmaniasis. After treatment with sodium stibogluconate, her symptoms resolved, blood counts improved, and skin hyperpigmentation diminished.

Diagnostic / clinical pearl

In immunosuppressed patients from non-endemic areas, visceral leishmaniasis should be considered when presenting symptoms overlap with autoimmune disease flares, especially in the absence of travel history to endemic regions.

Why it matters

This case highlights the utility of targeted next-generation sequencing in diagnosing infections that may mimic autoimmune conditions, facilitating timely and appropriate treatment.

Source

Published in Int J Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.